Incretin

Results: 39



#Item
21COMMONWEALTH OF KENTUCKY CABINET FOR HEALTH AND FAMILY SERVICES DEPARTMENT FOR MEDICAID SERVICES PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE MEETING Capital Annex -Room[removed]Capital Avenue Frankfort, Kentucky 40601

COMMONWEALTH OF KENTUCKY CABINET FOR HEALTH AND FAMILY SERVICES DEPARTMENT FOR MEDICAID SERVICES PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE MEETING Capital Annex -Room[removed]Capital Avenue Frankfort, Kentucky 40601

Add to Reading List

Source URL: chfs.ky.gov

Language: English - Date: 2014-11-27 00:52:35
22Japan-Mexico WS Abstract of Presentation Presentation Title: Free Fatty Acid Receptor GPR120: Function and Pharmacology Abstract:

Japan-Mexico WS Abstract of Presentation Presentation Title: Free Fatty Acid Receptor GPR120: Function and Pharmacology Abstract:

Add to Reading List

Source URL: www.jst.go.jp

Language: English - Date: 2009-06-30 21:15:57
23June 5, 2014 Janet Woodcock, M.D. Director Center for Drug Evaluation and Research Food and Drug Administration Department of Health and Human Services

June 5, 2014 Janet Woodcock, M.D. Director Center for Drug Evaluation and Research Food and Drug Administration Department of Health and Human Services

Add to Reading List

Source URL: www.citizen.org

Language: English - Date: 2014-06-18 15:48:36
24Continuing Education Discussion Guide A Guide to Emerging Treatments for Type 2 Diabetes: Focus on Incretin Therapies This continuing education discussion guide is part of an educational initiative designed to provide

Continuing Education Discussion Guide A Guide to Emerging Treatments for Type 2 Diabetes: Focus on Incretin Therapies This continuing education discussion guide is part of an educational initiative designed to provide

Add to Reading List

Source URL: www.ashpadvantagemedia.com

Language: English - Date: 2014-02-04 15:23:23
25STATE OF MICHIGAN DEPARTMENT OF ENERGY, LABOR & ECONOMIC GROWTH OFFICE OF FINANCIAL AND INSURANCE REGULATION Before the Commissioner of Financial and Insurance Regulation In the matter of

STATE OF MICHIGAN DEPARTMENT OF ENERGY, LABOR & ECONOMIC GROWTH OFFICE OF FINANCIAL AND INSURANCE REGULATION Before the Commissioner of Financial and Insurance Regulation In the matter of

Add to Reading List

Source URL: www.michigan.gov

Language: English - Date: 2012-12-07 20:40:37
26building a brighter future: addressing challenges in patient care Symposium agenda 15 September 2014, 9.00–16.15 Beringer Hall (Hall D)

building a brighter future: addressing challenges in patient care Symposium agenda 15 September 2014, 9.00–16.15 Beringer Hall (Hall D)

Add to Reading List

Source URL: www.novonordiskateasdsymposium.com

Language: English - Date: 2014-06-10 07:08:17
27Report on the Deliberation Results August 25, 2009 Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau Ministry of Health, Labour and Welfare

Report on the Deliberation Results August 25, 2009 Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau Ministry of Health, Labour and Welfare

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2014-03-10 21:30:33
28What’s “hot” about thermogenic agents

What’s “hot” about thermogenic agents

Add to Reading List

Source URL: dpic.org

Language: English - Date: 2013-06-09 23:17:15
29Microsoft PowerPoint - Chapter 1 figures.ppt

Microsoft PowerPoint - Chapter 1 figures.ppt

Add to Reading List

Source URL: media.wiley.com

Language: English - Date: 2013-08-24 10:12:06
30BYETTA® exenatide injection DESCRIPTION BYETTA® (exenatide) is a synthetic peptide that has incretin-mimetic actions and was originally identified in the lizard Heloderma suspectum. BYETTA enhances glucose-dependent in

BYETTA® exenatide injection DESCRIPTION BYETTA® (exenatide) is a synthetic peptide that has incretin-mimetic actions and was originally identified in the lizard Heloderma suspectum. BYETTA enhances glucose-dependent in

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:10:18